Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed attachment file name title grouped question UIN question first answered answering member label
tabling member	label

Search

1045911

	registered interest
	date	22/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Continuing Care
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people received continuing health care in each Care Commission Group; and the cost of that care in each of the last five years.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	211100
	answer	answer is ministerial correction date of answer 28/01/2019 answer text <p>A table showing the number of cases found eligible for NHS Continuing Healthcare (CHC) during the years from 2013-14 to 2017-18 is attached. The table refers to the clinical commissioning groups (CCGs) at that time; the total is for both standard and fast track NHS CHC.</p><p> </p><p>Tables showing CCG total NHS CHC expenditure by year, 2013-14 to 2017-18 is attached. Due to different number of weeks paid for in a care package, it is not possible to calculate an average package cost. Activity and cost data cannot therefore be used to approximate cost per person.</p> answering member constituency Gosport answering member printed Caroline Dinenage attachment 1 file name PQ211100 Annex B cost of CHC by CCG.xlsx title PQ211100 attached table 2 file name PQ211100 Annex A Number eligible by CCG format.xlsx title PQ211100 attached table question first answered 28/01/2019 14:37:07 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	394 label Biography information for Mr Clive Betts

1082575

	registered interest
	date	06/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Respite Care
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much funding allocated to councils for respite care has been accessed to date; and what steps his Department is taking to encourage carers to make use of that support.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	229090
	answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>Since 2015, the National Health Service contribution to the Better Care Fund (BCF) has included funding to support the implementation of the Care Act 2014, including £130 million which has been made available each year for Carers’ Breaks via the NHS clinical commissioning groups (CCG) minimum contribution to the BCF.</p><p>Locally agreed between local authorities (LAs) and CCGs, joint BCF plans set out the level of resource that will be dedicated to carer-specific support, including carers’ breaks, and identify how the chosen methods for supporting carers will help to meet key outcomes. These BCF plans are agreed locally at Health and Wellbeing Board level as part of the BCF Assurance process, and funding is released under the premise that the requirements and conditions of the Fund are met. The local level allocation data is not readily available at a national level.</p><p>We recognise the importance of carers being able to take a break from their caring role. Through the Carers Action Plan, we have committed to promoting best practice for LAs, service providers and commissioners on carer breaks and respite care. In doing so this will support them to help carers to take a break by highlighting best practice and provide advice and information for carers seeking respite breaks.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 11/03/2019 17:10:29 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	394 label Biography information for Mr Clive Betts

1082576

	registered interest
	date	06/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Care Workers: Registration
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether the Government plans to introduce a requirement for social care workers in England to be registered.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	229091
	answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>Care workers in England are subject to employer checks and controls including a Disclosure and Barring Service check. Since 2015, healthcare assistants and care support workers have been expected to achieve the care certificate before working unsupervised. This contains 15 standards setting out a common set of skills, knowledge and behaviours that are needed in order to provide safe, high quality and compassionate care.</p><p> </p><p>The Government is committed to a proportionate system of safeguards for the professionals who work in the health and care system. Statutory professional regulation should only be used in cases where the risks to the public cannot be mitigated in other ways. We have no plans to introduce a requirement for social care workers in England to be registered in England at this time.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 11/03/2019 17:07:02 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	394 label Biography information for Mr Clive Betts

1082577

	registered interest
	date	06/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Care Workers: Registration
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department is planning on introducing a requirement for social care workers to register with Care Quality Commission.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	229092
	answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>Care workers in England are subject to employer checks and controls including a Disclosure and Barring Service check. Since 2015, healthcare assistants and care support workers have been expected to achieve the care certificate before working unsupervised. This contains 15 standards setting out a common set of skills, knowledge and behaviours that are needed in order to provide safe, high quality and compassionate care.</p><p> </p><p>The Government is committed to a proportionate system of safeguards for the professionals who work in the health and care system. Statutory professional regulation should only be used in cases where the risks to the public cannot be mitigated in other ways. We have no plans to introduce a requirement for social care workers in England to be registered in England at this time.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 11/03/2019 18:14:04 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	394 label Biography information for Mr Clive Betts

1110551

	registered interest
	date	09/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps is the Government taking to ensure timely access to maintenance medication for people with cancer.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	242692
	answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>The Department fully understands that maintaining access to cancer medication is vitally important to many people in this country.</p><p> </p><p>There is already a team within the Department that deals with medicine supply issues arising both in the community and hospitals. We have well established procedures to deal with medicine shortages, from whatever cause, and work closely with the Medicines and Healthcare products Regulatory Agency, the pharmaceutical industry, NHS England and others operating in the supply chain to help prevent shortages and to ensure that the risks to patients are minimised when they do arise.</p><p> </p><p>If we are aware of issues with cancer medications we work with national clinical experts to advise on management plans and ensure that appropriate information is provided to the National Health Service and specialist patient groups.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 12:58:08 answering member 4455 label Biography information for Seema Kennedy
	tabling member	394 label Biography information for Mr Clive Betts

1110552

	registered interest
	date	09/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the appraisal process for personalised treatments for small patient groups.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	242693
	answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body that provides guidance on the prevention and treatment of ill health and the promotion of good health and social care. Through its technology appraisal and highly specialised technologies programmes, NICE plays an important role in ensuring that patients are able to benefit from effective new treatments, including treatments for small numbers of patients. NICE has recommended a number of drugs for small patient populations through these programmes that are now routinely funded by the National Health Service for eligible patients.</p><p> </p><p>NICE periodically reviews its methods and processes to ensure that they keep pace with developments in science and healthcare. NICE will be carrying out a review of its technology appraisal and highly specialised technologies methods in 2019/20.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 12:55:57 answering member 4455 label Biography information for Seema Kennedy
	tabling member	394 label Biography information for Mr Clive Betts

1121970

	registered interest
	date	18/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 April 2019 to Question 242692 on Cancer: Drugs, what steps the Government is taking to give timely NICE and NHS approval to enable access to maintenance medication for people with cancer.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	245610
	answer	answer is ministerial correction date of answer 25/04/2019 answer text <p>Through its technology appraisal programme, the National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether drugs and other treatments represent an effective use of NHS resources. NHS England is legally required to fund cancer drugs recommended in NICE technology appraisal guidance.</p><p>The Government wants patients with cancer to be able to benefit from rapid access to effective new drugs, including for maintenance treatment. Under arrangements introduced in 2016, NICE now develops technology appraisal guidance for the NHS on all new cancer drugs. Wherever possible, NICE aims to issue draft guidance on new cancer drugs before licensing and to publish final guidance within 90 days of licensing.</p><p>Funding is available through the Cancer Drugs Fund from the point at which NICE draft recommendations are published, or if the drug is not currently licensed, from the point of licensing. This ensures patients are able to benefit from effective new cancer drugs as quickly as possible.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 25/04/2019 14:05:35 answering member 4455 label Biography information for Seema Kennedy
	tabling member	394 label Biography information for Mr Clive Betts

1124146

	registered interest
	date	01/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 25 April 2019 to Question 245610, how many forms of cancer have no maintenance drug available at any stage in the treatment plan.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	249828
	answer	answer is ministerial correction date of answer 08/05/2019 answer text <p>The information requested is not available.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 08/05/2019 13:54:02 answering member 4455 label Biography information for Seema Kennedy
	tabling member	394 label Biography information for Mr Clive Betts

1132282

	registered interest
	date	14/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Genomics: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of patients that will benefit from whole genome sequencing in the first year of its introduction; and what steps is he taking to ensure the adequacy of trained professionals to provide that service.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	264725
	answer	answer is ministerial correction date of answer 19/06/2019 answer text <p>As part of the NHS Long Term Plan, the National Health Service has committed to sequencing 500,000 whole genomes by 2023/24.</p><p>During 2019, the NHS will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test;</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and Acute Myeloid Leukaemia.</p><p> </p><p>As the price of whole genome sequencing falls and the evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 19/06/2019 16:17:13 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	394 label Biography information for Mr Clive Betts

1135182

	registered interest
	date	27/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Genomics: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, which diagnostic tests will whole genome sequencing replace, particularly for blood cancers.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	270281
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>During 2019, the National Health Service will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and acute myeloid leukaemia.</p><p> </p><p>WGS will only replace existing diagnostic tests once the testing is demonstrated to be clinically safe to replace existing diagnostic testing. Initially, existing diagnostic testing will continue to be performed alongside WGS testing where clinically appropriate. This will continue until WGS is able to fully support clinical decision making within clinically appropriate timescales.</p><p>Current testing for blood cancers includes a number of diagnostic tests, the current expectation is that WGS will not be used to replace tests that require very fast turnaround times (under 24 hours) or high sensitivity.</p><p>WGS and non-WGS testing that will be available as part of clinical care is outlined in the National Genomic Test Directory at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/publication/national-genomic-test-directories/" target="_blank">https://www.england.nhs.uk/publication/national-genomic-test-directories/</a></p><p> </p><p>The UK Genetic Testing Network (UKGTN) published the NHS Directory of Genetic Disorders/Genes for Diagnostic Testing, which evaluated and recommended genetic tests for rare and inherited disorders for the National Health Service across the UK. However, there was not an equivalent for cancer genomic testing. The National Genomic Test Directory specifies which genomic tests are commissioned by the NHS in England, the technology by which they are available, and the patients who will be eligible to access to a test.</p><p>The National Genomic Test Directory will be updated on an annual basis and NHS England will implement a clear and transparent process, supported by a Clinical and Scientific Expert Panel, to determine which tests are available within the NHS. This will include reviewing any tests that may be retired or replaced by more modern technology, such as WGS. As the price of WGS falls and the clinical evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 270282 270283 question first answered 05/07/2019 09:24:02 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	394 label Biography information for Mr Clive Betts